n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® PCR/CE FMR1
AmplideX® mPCR FMR1
AmplideX® FMR1 Controls
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
AmplideX® PCR/CE
SMN1
Kit
AmplideX® PCR/CE
SMN1/2
Kit
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
HTT
Kit
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
QuantideX® NGS RNA Lung Cancer Kit
QuantideX® NGS DNA Hotspot 21 Kit
Custom & Companion Diagnostics
Commercialization
Product Approval
Development
Discovery
Partnered R&D
Tumor Bank
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Tumor Bank
Custom Controls
Armored Reagents
In Vitro
Transcribed RNA
Plasmid DNA
Companion Diagnostics
Commercialization
Product Approval
Development
Discovery
Partnered R&D
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X
Leukemia
Dementia
Other Resources
Videos
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
About
Leadership Team
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Contact
Careers
Search
Publications
Home
Publications
Verification of a Single-tube PCR/CE Kit for SMN1/2 Copy Number and Variants Associated with Gene Duplication and SMA Disease Severity
Verification of a Single-tube PCR/CE Kit for SMN1/2 Copy Number and Variants Associated with Gene Duplication and SMA Disease Severity
April 17, 2020
View the full poster
Back To
Top
